CIK 0001299130 · Accelerated filer
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Sign in to watch- Ticker
- PACB
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 161590339
- Phone
- 650-521-8000
- Business address
- 1305 O'BRIEN DRIVE, MENLO PARK, CA, 94025
- Former names
- PACIFIC BIOSCIENCES OF CALIFORNIA INC, NANOFLUIDICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,087,330
- in 2 filings, $2.1M under 10b5-1 plans
Net −$2,087,330. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 46 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-17 | Ericson William W. Director | Other acquisition | +1,268 | 1,336 | ||
| 2022-03-02 | Farmer Michele See Remarks | Grant or award | +22,500 | 62,500 | ||
| 2022-03-02 | Farmer Michele See Remarks | Grant or award · Stock Option (right to buy) | +44,800 | 44,800 | ||
| 2022-03-02 | Kim Susan G. See Remarks | Grant or award | +40,000 | 174,966 | ||
| 2022-03-02 | Kim Susan G. See Remarks | Grant or award · Stock Option (right to buy) | +239,000 | 239,000 | ||
| 2022-03-02 | Fromen Peter See Remarks | Grant or award | +50,000 | 190,280 | ||
| 2022-03-02 | Fromen Peter See Remarks | Grant or award · Stock Option (right to buy) | +298,700 | 298,700 | ||
| 2022-03-02 | Van Oene Mark See Remarks | Grant or award | +72,500 | 366,020 | ||
| 2022-03-02 | Van Oene Mark See Remarks | Grant or award · Stock Option (right to buy) | +433,200 | 433,200 | ||
| 2022-03-02 | HENRY CHRISTIAN O See Remarks | Grant or award | +107,500 | 779,858 | ||
| 2022-03-02 | HENRY CHRISTIAN O See Remarks | Grant or award · Stock Option (right to buy) | +642,300 | 642,300 | ||
| 2022-02-17 | Kim Susan G. Chief Financial Officer | Sale | −1,062 | $11.06 | $12K | 134,966 |
| 2022-02-17 | HENRY CHRISTIAN O President & CEO | Sale | −2,122 | $11.09 | $24K | 672,358 |
| 2022-02-16 | ORDONEZ KATHY Director | Sale | −3,280 | $11.50 | $38K | 18,595 |
| 2022-01-14 | MOHR MARSHALL Director | Option exercise | +25,000 | $3.57 | $89K | 25,000 |
| 2022-01-14 | MOHR MARSHALL Director | Option exercise · Stock Option (right to buy) | +25,000 | 0 | ||
| 2022-01-11 | Van Oene Mark Chief Operating Officer | Sale | −41,480 | $14.23 | $590K | 293,520 |
| 2022-01-11 | Fromen Peter Chief Commercial Officer | Sale | −19,720 | $14.30 | $282K | 140,280 |
| 2021-09-29 | Kim Susan G. Chief Financial Officer | Sale | −20,272 | $25.75 | $522K | 136,028 |
| 2021-09-16 | HENRY CHRISTIAN O President & CEO | Sale | −90,520 | $26.91 | $2.4M | 674,480 |
Page 9 of 29 · 561 trades